Need to calculate global cardiovascular risk in hypertensive patients
Keywords:
arterial hypertension, cardiovascular risk stratificationAbstract
Faced with the global health threat posed by cardiovascular diseases, the HEARTS initiative of the World Health Organization supports countries to strengthen measures to prevent cardiovascular diseases, such as cardiovascular risk stratification. The authors propose as an objective to substantiate the need of calculating global cardiovascular risk in primary health care. Two forms are used to estimate global cardiovascular risk: qualitative and quantitative. In the latter, certain cardiovascular risk factors are considered and expressed in terms of low, medium, and high risk. There are several systems and in different supports that allow their use in various scenarios; in addition they make it possible to plan the follow-up and treatment according to risk. Although they have disadvantages, their use is recommended to prevent complications and death. The calculation of global cardiovascular risk in hypertensive patients is a measure of great value for predicting mortality, establishing the therapeutic strategy, and planning patient follow-up. Its use should be extended and consolidated at all levels of health care.Downloads
References
2. Bonet Gorbea M, Varona Pérez P. III Encuesta nacional de factores de riesgo y actividades preventivas de enfermedades no trasmisibles. Cuba 2010-2011 [Internet]. La Habana: Editorial Ciencias Médicas; 2014 [citado 07/02/2023]. Disponible en: https://extranet.who.int/ncdccs/Data/CUB_C5_Encuesta_nacional_FR_2010-11.pdf
3. World Health Organization. The Global Hearts Initiative Working Together to Promote Cardiovascular Health [Internet]. Geneva: WHO; 2016 [citado 07/02/2023]. Disponible en: https://www.cdc.gov/globalhealth/healthprotection/resources/pdf/HEARTS_Infographic.pdf
4. Al-Makki A, DiPette D, Whelton PK, et al. Hypertension pharmacological treatment recommendations in adults. A World Health Organization guidelines executive summary. Hypertension. 2022;79(1):293-301. DOI: 10.1161/HYPERTENSIONAHA.121.18192.
5. Orduñez P, Tajer C, Gaziano T, et al. La aplicación HEARTS: una herramienta clínica para el manejo del riesgo cardiovascular y la hipertensión en la atención primaria de salud. Rev Panam Salud Pública. 2022;46:e46. DOI: 10.26633/RPSP.2022.46.
6. Pérez Caballero MD, Valdés González Y, Pérez Perea L, et al. Hipertensión arterial en el adulto. Guía de actuación para la atención primaria de salud [Internet]. La Habana: Ministerio de Salud Pública; 2021 [citado 07/02/2023]. Disponible en: https://temas.sld.cu/hipertension/files/2022/02/GU%C3%8DA-DE-ACTUACI%C3%93N-FINAL-6.12.21.pdf
7. Organización Panamericana de la Salud. Calculadora de riesgo cardiovascular [Internet]. Washington DC: OPS; 2021 [citado 07/02/2023]. Disponible en: https://www.paho.org/es/hearts-americas/calculadora-riesgo-cardiovascular
8. Castaño Cifuentes O, Hoyos Zuluaga AL, Palacios Cuesta MY, et al. Antecedentes, hábitos, características de género y escalas de riesgo cardiovascular en trabajadores hospitalarios. Rev Asoc Esp Espec Med Trab [Internet]. 2022 [citado 07/02/2023];31(1):41-9. Disponible en: https://scielo.isciii.es/pdf/medtra/v31n1/1132-6255-medtra-31-01-41.pdf
9. Alcocer LA, Lozada O, Fanghänel G, et al. Global cardiovascular risk stratification: comparison of the Framingham method with the SCORE method in the Mexican population. Cir Cir [Internet]. 2011 [citado 07/02/2023];79(2):168-74. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21631978/
10. Lu X, Liu Z, Cui Q, et al. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J. 2022;43(18):1702-11. DOI: 10.1093/eurheartj/ehac093.
11. Gort-Hernández M, Mamane-Malam I, Márquez-Blanco K, et al. Categoría de riesgo cardiovascular total en pacientes hipertensos. Rev Cienc Méd Pinar Río [Internet]. 2023 [citado 06/10/2023];27(0):e5801. Disponible en: http://revcmpinar.sld.cu/index.php/publicaciones/article/view/5801
12. Hechavarría Matos S, Montes de Oca Carmenaty M, Chaveco Bello LL, et al. Estimación del riesgo cardiovascular total en pacientes con hipertensión arterial. Inmedsur [Internet]. 2020 [citado 06/10/2023];3(1):23-31. Disponible en: http://www.inmedsur.cfg.sld.cu/index.php/inmedsur/article/view/58
13. Díaz-Esquivel AM, Pereda-Rodríguez Y, Linares-Montano A, et al. Estimación del riesgo cardiovascular en pacientes hipertensos. Policlínico Docente Universitario Luis Augusto Turcios Lima, 2021. Rev Cienc Méd Pinar Río [Internet]. 2022 [citado 06/10/2023];26(1):e5365. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942022000100010&lng=es
14. Dueñas-Herrera AF, Armas-Rojas NB, Prohias-Martínez J. Determinación del Riesgo Cardiovascular Global. Importancia de su implementación sistemática en el Sistema Nacional de Salud. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2017 [citado 06/10/2023];23(2):308-11. Disponible en: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/689
15. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens [Internet]. 2023 [citado 06/10/2023];41(12):1874-2071. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37345492/
Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.